Recall Ledger

Boswellia Herbal Supplement recall (A New Life Herbs, LLC)

FoodClass IITerminated

Summary: A New Life Herbs, LLC is recalling Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory properties, useful for pain & inflammation; packaged in a 2 oz. glass dropper bottle, UPC 284260392420. Reason: Unapproved drug claims on product labeling and product misbranded due to no Supplement Facts label.

What is being recalled

Boswellia Herbal Supplement, 1:5 Alcohol Double Extract, Extracted from Frankincense with powerful anti-inflammatory properties, useful for pain & inflammation; packaged in a 2 oz. glass dropper bottle, UPC 284260392420

Why

Unapproved drug claims on product labeling and product misbranded due to no Supplement Facts label

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

AL, AZ, CA, GA, IL, IN, MN, MO, MS, NC, NY, TN (states named: Alabama, Arizona, California, Georgia, Illinois, Indiana, Minnesota, Missouri, Mississippi, North Carolina, New York, Tennessee)

How to tell if yours is affected

T848B EXP 11/30 T836B EXP 10/30 T808B EXP 9/30 T771B EXP 7/30 T723B EXP 3/30 T696B EXP 1/29 T655B EXP 10/29 T594B EXP 4/29 T536B EXP 10/28

What to do

Check the product name and the codes above against what you have. If they match, do not eat or use it. Throw it away or return it to the store where you bought it, and contact the recalling company with questions.

Recall facts

Recall numberH-0343-2026
CategoryFood
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusTerminated
Recall startedNovember 20, 2025
ReportedDecember 31, 2025
CompanyA New Life Herbs, LLC
Company locationSomerville, TN, United States
Initiated byVoluntary: Firm initiated
Quantity278 bottles

More recalls from A New Life Herbs, LLC · all food recalls · recalls from November 2025

Official FDA record